Targeted News Service

Haynes & Boone Guides PATHOMIQ in AI Diagnostics Deal With Myriad Genetics to Transform Cancer Care
February 28, 2025

DALLAS, Texas, Feb. 28 -- Haynes and Boone, a law firm, issued the following news release:

* * *

Haynes Boone Guides PATHOMIQ in AI Diagnostics Deal with Myriad Genetics to Transform Cancer Care

Haynes Boone represented PATHOMIQ, Inc., a pioneer in artificial intelligence-driven diagnostics, in securing an exclusive U.S. licensing agreement with Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine. The new co . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form